Skip to content

Supplier News

Sandoz to acquire respiratory generics maker Oriel

Sandoz plans to acquire U.S. pharmaceuticals company Oriel Therapeutics, which the Novartis division said would give it exclusive rights to a portfolio of generic drug candidates and related technologies in the inhalable respiratory drug market. Terms of the deal weren’t disclosed.

Mylan adds new clozapine tablet dosages

Mylan Pharmaceuticals Inc. has launched 50 mg and 200 mg tablets for its geneirc antipsychotic drug clozapine. The pharmaceutical company, a subsidiary of Mylan Inc., said Monday that those clozapine dosages had U.S. sales of about $13.5 million last year, according to IMS Health data.

American Greetings unveils On Tap birthday cards

American Greetings Corp. is providing a more interactive way to send a birthday greeting. The company said this spring it plans to roll out an innovative new greeting card dubbed On Tap, which combines a funny birthday greeting with an audio-visual element.

Unilever names Minvielle to head North America unit

Unilever has appointed Eugenio Minvielle as executive vice president of its North American business. Minvielle, 45, who joins the company from Nestle, will be responsible for Unilever’s $10 billion operations in the United States, Canada and the Caribbean.

CVS, Navarro to carry Fresh Harvest snack bars

Fresh Harvest Products Inc. plans to roll out its Wings of Nature organic snack bars to CVS and Navarro Discount Pharmacies drug stores in South Florida. The natural and organic food and beverage company said this week that the products will become available next month in about 80 CVS locations.

Galderma adds new nozzle to Clobex Spray

Galderma Laboratories has rolled out a new nozzle for Clobex Spray, a super-potent topical steroid for moderate to severe plaque psoriasis. The company said Tuesday that the new packaging for Clobex Spray (clobetasol propionate 0.

Skinvisible inks pact to develop women’s Rx product

Skinvisible Inc. has entered into an agreement with specialty pharmacy firm Women’s Choice Pharmaceuticals to develop a prescription formulation using Skinvisible’s patented Invisicare polymer delivery system for topical dermatology products.